EFSA to Hold Workshop with Stakeholders on Draft Guidance for GM Plant Comparators
News Dec 01, 2010
- Food Ingredients First, Dec 1, 2010 - - The current approach followed by risks assessors worldwide is to carry out comparative assessments of the GM crop plant and its conventional crop counterpart to determine if the GM plant, such as for example GM maize, is as safe as its conventional non-GM counterpart. 01 Dec 2010 --- The European Food Safety Authority (EFSA) has announced it will hold a consultative workshop in March 2011 with scientists and risk assessors from EU Member States, industry and non-governmental organisations (NGOs), to discuss its draft guidance document on the selection of comparators for the risk assessment of GM plants. The workshop will be held following a public consultation on the draft guidance document.??The choice of an appropriate comparator is the cornerstone of the risk assessment of GMOs. The current approach followed by risks assessors worldwide is to carry out comparative assessments of the GM crop plant and its conventional crop counterpart to determine if the GM plant, such as for example GM maize, is as safe as its conventional non-GM counterpart.??EFSA’s GMO Panel took the initiative to strengthen the guidance to be followed by applicants when selecting appropriate comparators to be used in the risk assessment of GM plants. The draft document was launched for public consultation on 15 November: Scientists and other stakeholders can submit their comments to EFSA up to 15 January.??As part of its ongoing consultation with stakeholders, EFSA experts at the March workshop will discuss an analysis of the comments received during the public consultation and exchange views on the comparative assessment approach utilised to assess the safety of GM plants, as well as the underlying concept of substantial equivalence.??The GMO Panel regularly reviews its guidance taking into account scientific developments and experience gained through its risk assessments. In order to engage with interested parties and seek input to help inform its risk assessment work, EFSA always carries out a public consultation on its draft guidance documents. This was the case for instance for EFSA’s recently updated guidance for the environmental risk assessment (ERA) of GM applications submitted for authorisation in the European Union.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE